EUVIMEDEUVIMED entdecken
Crossref

Metabolically healthy obesity in adults with X-linked hypophosphatemia

Anne-Lise Lecoq iD, Katharina Schilbach iD, Laurence Rocher, Séverine Trabado, Karine Briot iD, Julia Herrou iD, Aurélie Forbes, Anthony Garnier, Marie Piketty iD, Martin Bidlingmaier iD, Anya Rothenbuhler, Agnès Linglart iD und 3 weitere

European Journal of Endocrinology · 2024

DOI: 10.1093/ejendo/lvae089 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Endocrinology, 2024. Verfasst von Anne-Lise Lecoq und 14 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, AP-HP, Hôpital Bicêtre, Service d'Endocrinologie et des Maladies de …. Hauptthemen laut MEDLINE: Familial Hypophosphatemic Rickets, Fibroblast Growth Factor-23. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

X-linked hypophosphatemia (XLH) is characterized by increased concentrations of circulating fibroblast growth factor 23 (FGF-23) resulting in phosphate wasting, hypophosphatemia, atypical growth plate and bone matrix mineralization. Epidemiologic studies suggest a relationship between FGF-23, obesity, and metabolic dysfunction. The prevalence of overweight and obesity is high in children with XLH. We aimed to evaluate the prevalence of obesity and metabolic complications in adults with XLH.

Methods

We conducted a prospective cohort study in adult XLH patients from a single tertiary referral center. The proportion of patients with a BMI >25 kg/m2 was the main outcome measure. Body fat mass percentage (FM%) and adipose tissue surfaces were secondary outcome measures. Glucose homeostasis (plasma glucose and insulin concentrations after fasting and 2 hours after an oral glucose tolerance test) was explored in a subgroup of patients and compared with age-, sex-, and BMI-matched healthy controls.

Results

Among 113 evaluated patients, 85 (75%) were female and 110 (97%) carried a PHEX mutation. Sixty-three (56%) patients were overweight or obese, with a median BMI of 25.3 [IQR, 22.7; 29.2] kg/m2. BMI was correlated with FM%, abdominal and thigh subcutaneous and intra-abdominal adipose tissue surfaces. The prevalence of impaired fasting glucose, impaired glucose tolerance, and diabetes was not different between XLH patients and matched controls.

Conclusion

The prevalence of overweight and obesity is high among XLH patients and is associated with excess fat mass. However, the prevalence of glucose homeostasis abnormalities is not increased in patients compared to healthy controls, suggesting that metabolically healthy overweight or obesity predominates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Familial Hypophosphatemic RicketsFibroblast Growth Factor-23HumansFemaleMaleAdultProspective StudiesMiddle AgedObesity, Metabolically BenignYoung AdultFibroblast Growth FactorsCohort StudiesPrevalenceBody Mass IndexObesityOverweightPHEX Phosphate Regulating Neutral Endopeptidase

Stichwörter der Autor:innen

FGF-23X-linked hypophosphatemiadiabetes mellitusinsulin resistancemetabolic syndromeobesity

Substanzen

Fibroblast Growth Factor-23FGF23 protein, humanFibroblast Growth FactorsPHEX Phosphate Regulating Neutral Endopeptidase

Autor:innen und Institutionen

  • Université Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, AP-HP, Hôpital Bicêtre, Service d'Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares du Métabolisme…
  • Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, 80336 Munich, Germany.
  • Université Paris-Saclay, BIOMAPS, UMR1281, AP-HP, Hôpital Antoine Béclère, Service de Radiologie, 92140 Clamart, France.
  • Université Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, AP-HP, Hôpital Bicêtre, Laboratoire de Génétique Moléculaire, Pharmacogénétique et Hormonologie, 94275 Le Kremlin Bicêtre Cedex, France.
  • Université Paris Cité, AP-HP, Hôpital Cochin, Service de Rhumatologie, Centre de Référence des Maladies Rares du Métabolisme du Calcium et du Phosphate Filière OSCAR, 75014 Paris, France.
  • AP-HP, Hôpital Bicêtre, Service de Biophysique et Médecine Nucléaire, 94275 Le Kremlin Bicêtre Cedex, France.

ORCID-Profile: Anne-Lise Lecoq, Katharina Schilbach, Karine Briot, Julia Herrou, Marie Piketty, Martin Bidlingmaier, Agnès Linglart, Peter Kamenický

Zitieren

APA

Lecoq, A. L., Schilbach, K., Rocher, L., Trabado, S., Briot, K., Herrou, J., Forbes, A., Garnier, A., Piketty, M., Bidlingmaier, M., Rothenbuhler, A., Linglart, A., Carette, C., Chaumet-Riffaud, P., & Kamenický, P. (2024). Metabolically healthy obesity in adults with X-linked hypophosphatemia. European Journal of Endocrinology. https://doi.org/10.1093/ejendo/lvae089

Vancouver

Lecoq AL, Schilbach K, Rocher L, Trabado S, Briot K, Herrou J, et al. Metabolically healthy obesity in adults with X-linked hypophosphatemia. European Journal of Endocrinology. 2024. doi:10.1093/ejendo/lvae089

BibTeX
@article{Lecoq2024,
  author = {Lecoq, Anne-Lise and Schilbach, Katharina and Rocher, Laurence and Trabado, Séverine and Briot, Karine and Herrou, Julia and Forbes, Aurélie and Garnier, Anthony and Piketty, Marie and Bidlingmaier, Martin and Rothenbuhler, Anya and Linglart, Agnès and Carette, Claire and Chaumet-Riffaud, Philippe and Kamenický, Peter},
  title = {Metabolically healthy obesity in adults with X-linked hypophosphatemia},
  journal = {European Journal of Endocrinology},
  year = {2024},
  doi = {10.1093/ejendo/lvae089}
}
Kostenlos starten →